Karen Schwartz
-
- Cardiomyopathy and Myosin Studies 11
- Cardiovascular Effects of Exercise 7
- Surgery top 2%
- Cholesterol and Lipid Metabolism 4
- Lipoproteins and Cardiovascular Health 3
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 4
- Molecular Biology top 5%
- Nuclear Structure and Function 4
- RNA modifications and cancer 4
- Muscle Physiology and Disorders 3
- Biochemistry top 5%
- Co-authors
- Richard M. LawnDavid P. WadeRobert M. RapoportFerid MuradScott A. WaldmanRaymond J. WinquistC WisnewskyElizabeth P. Faison
- Journals
- Journal of Biological Chemistry (6 papers)European Heart Journal (4 papers)American Journal of Physiology-Heart and Circulatory Physiology (4 papers)
- Partner nations
- United StatesFranceHungary
In The Last Decade
Karen Schwartz
50 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Cardiology and Cardiovascular Medicine 1.3k
- Surgery 1.4k
- Cancer Research 437
- Molecular Biology 1.8k
- Biochemistry 167
Countries citing papers authored by Karen Schwartz
This map shows the geographic impact of Karen Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Schwartz more than expected).
Fields of papers citing papers by Karen Schwartz
This network shows the impact of papers produced by Karen Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Schwartz. The network helps show where Karen Schwartz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karen Schwartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2020 | 1 | |
| 3 | 2012 | 3 | |
| 4 | 2009 | 9 | |
| 5 | 2000 | 357 | |
| 6 | The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathwaybreakdown → | 1999 | 611 |
| 7 | 1997 | 76 | |
| 8 | 1997 | 72 | |
| 9 | 1996 | 76 | |
| 10 | 1995 | 73 | |
| 11 | 1994 | 8 | |
| 12 | 1993 | 162 | |
| 13 | 1991 | 122 | |
| 14 | 1990 | 17 | |
| 15 | 1990 | 383 | |
| 16 | 1990 | 1 | |
| 17 | 1989 | 56 | |
| 18 | 1986 | 33 | |
| 19 | Isozymes of Myosin in Regenerating Rat Muscles | 1985 | 1 |
| 20 | 1985 | 123 |
About Karen Schwartz
Karen Schwartz is a scholar working on Cardiology and Cardiovascular Medicine, Conservation and Applied Microbiology and Biotechnology, having authored 54 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (11 papers), Cardiovascular Effects of Exercise (7 papers), Nuclear Structure and Function (4 papers), Cholesterol and Lipid Metabolism (4 papers), Protease and Inhibitor Mechanisms (4 papers), RNA modifications and cancer (4 papers), Muscle Physiology and Disorders (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.3k citations), Surgery (1.4k citations) and Cancer Research (437 citations). Karen Schwartz has collaborated with scholars based in United States, France and Hungary. Frequent co-authors include Richard M. Lawn, David P. Wade, Robert M. Rapoport, Ferid Murad, Scott A. Waldman, Raymond J. Winquist, C Wisnewsky, Elizabeth P. Faison, Ashley M. Vaughan and J. Gordon Porter. Their work appears in journals such as Journal of Biological Chemistry, European Heart Journal, American Journal of Physiology-Heart and Circulatory Physiology, Journal of Clinical Investigation and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.